Alexandra Hams' life turned upside down after she noticed a lump on her two-year-old son's body while giving him a bath.

ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...

A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...

The boy, named Daoming, has been battling rhabdomyosarcoma — a type of soft tissue sarcoma affecting his brain and nose — for ...

The following is a summary of "Clinical course and prognostic factors of patients with dedifferentiated liposarcoma: a ...

SON-1010 is being studied as a combination therapy with trabectedin (Yondelis®), the first FDA-approved treatment for two types of advanced soft ...

Sarcomas are among the rarest and most enigmatic forms of cancer, accounting for just 1% of all adult cancer diagnoses ...

Telix Pharmaceuticals Limited today announces that a first patient has been dosed in the Phase 1 ZOLAR[1] trial of TLX300-CDx ...